Tactile/kinesthetic Stimulus Program
Launched by GONCA KARATAS BARAN · Aug 2, 2022
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a special program that uses touch and movement to help preterm infants learn how to suck and feed effectively. The goal is to see if this program can help these babies transition to full sucking and reduce their time in the hospital. The study is currently looking for participants, specifically babies born between 28 and 32 weeks of pregnancy who are stable and ready to start oral feeding.
To be eligible, babies must have good health indicators (like stable vital signs and certain scoring at birth) and must not have any serious medical issues that could interfere with feeding. Parents who choose to participate will see their babies receive this tactile/kinesthetic program, which involves gentle stimulation to encourage feeding abilities. It’s important to know that babies whose feeding is interrupted for more than one day due to health problems will be removed from the study. Overall, this trial aims to support preterm infants on their feeding journey and improve their hospital experience.
Gender
ALL
Eligibility criteria
- • Inclusion criteria
- • Born between 28-32 weeks of gestation,
- • Stable vital signs,
- • 1st and 5th minute APGAR score between 6-10,
- • Babies who have received mechanical ventilator or continuous positive air pressure (CPAP) or both support after 48 hours have passed after stabilization,
- • Does not have an anomaly that will prevent feeding,
- • Oral feeding decision has been made,
- • Babies of mothers who are willing to breastfeed their babies,
- • Babies of parents who volunteered to participate in the study will be taken.
- • Exclusion criteria
- • IUGG,
- • Infants with severe asphyxia,
- • Babies born with low birth weight according to their gestational week,
- • Having an anomaly that will prevent her from feeding,
- • Babies with unstable vital signs,
- • Babies with congenital anomalies or serious complications
- • Infants with intraventricular bleeding.
- • Dismissal Criteria
- • • Babies whose oral feeding process is interrupted for more than 1 day due to neonatal problems.
About Gonca Karatas Baran
Gonca Karatas Baran is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes. With a focus on innovative therapeutic areas, the organization collaborates with healthcare professionals and research institutions to design and implement rigorous clinical studies. Leveraging a comprehensive understanding of regulatory frameworks and ethical considerations, Gonca Karatas Baran ensures the highest standards of safety and efficacy in all trials. Their mission is to contribute to the development of groundbreaking therapies that address unmet medical needs and enhance the quality of life for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, Eyalet/Yerleşke, Turkey
Ankara, , Turkey
Patients applied
Trial Officials
GONCA K KARATAS BARAN
Study Director
Etlik Zubeyde Hanım Women's Health Care, Training and Research Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials